| Serial Number | 85694993 |
| Word Mark | CHAMPIONS TUMORGRAFT |
| Filing Date | Friday, August 3, 2012 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, August 28, 2020 |
| Registration Number | 4471792 |
| Registration Date | Tuesday, January 21, 2014 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 5, 2013 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "TUMORGRAFT" |
| Goods and Services | Medical research and development in the field of treatment for cancer and oncology, and treatment of inflammation and autoimmune diseases; Scientific research services for medical purposes; scientific research services for diagnosis and analysis of cancer; medical and scientific research in the fields of treatment for cancer and oncology, and treatment of inflammation and autoimmune diseases; Medical research in the field of molecular signatures of tissues, namely, dna, rna, or proteins within a tumor, prediction of cancer risk, diagnosis, prognosis, response to therapy, and identification of new molecular targets for the development of more effective cancer prevention and personalized treatment programs; Analysis of the mode of action of chemical combinations on animals; biomedical research services; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of medical imaging; medical and scientific research in the field of cancer diseases; medical and scientific research, namely, conducting clinical trials; medical research; medical research services in the field of cancer; pharmaceutical research and development; pharmaceutical research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical testing services and information in the field of cancer research and disease classification; providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; research and development and consultation related thereto in the field of treatment and prevention of cancer diseases; research and development in the field of cancer diseases; research and development in the pharmaceutical and biotechnology fields; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; research in the field of cancer diseases; research on the subject of pharmaceuticals; scientific and technological services, namely, animal testing and modeling in the field of cancer diseases; scientific research; scientific research and development; scientific research consulting in the field of cancer diseases; scientific research for medical purposes in the area of cancerous diseases; scientific study and research in the fields of animal testing and modeling of medical devices and therapeutic agents; testing, inspection or research of pharmaceuticals, cosmetics or foodstuff |
| Goods and Services | Providing a database in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness, namely, providing data regarding tumor-specific molecular signatures, providing objective data on the effectiveness of a drug and diagnostic test and providing evidence-based treatment protocols by effectively comparing standard treatment therapies with clinical outcomes; providing an internet-accessible medical records portal for use by physicians, patients and researchers for the storage and accessibility of electronic data in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness; Medical diagnostic services for cancer treatment purposes in the field of molecular oncology, namely, medical diagnostic testing consisting of tumor testing, tumor profiling, molecular diagnostics, molecular tumor diagnostics, evaluation and testing of drug and treatment effectiveness, chemotherapy response and genomic pathway activation signaling; Medical diagnostic testing services in the fields of oncology and solid tumor pathology; Medical diagnostic services relating to the detection of cancer; medical diagnostic screening and analytical services in the field of medical diagnostic testing through isolation and extraction of cells for analysis and medical diagnostic screening and analytical services used in the oncology field; Medical and veterinary services in the fields of analysis and diagnosis of metastasizing cancer species with liquid samples and tissue samples of the patient |
| Pseudo Mark | CHAMPIONS TUMOR GRAFT |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, August 28, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, March 1, 2012 |
| First Use In Commerce Date | Thursday, March 1, 2012 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, August 28, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | Thursday, March 1, 2012 |
| First Use In Commerce Date | Thursday, March 1, 2012 |
| Party Name | Champions Biotechnology, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Hackensack, NJ 07601 |
| Party Name | Champions Biotechnology, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Hackensack, NJ 07601 |
| Party Name | Champions Biotechnology, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Hackensack, NJ 07601 |
| Event Date | Event Description |
| Friday, August 28, 2020 | CANCELLED SEC. 8 (6-YR) |
| Wednesday, May 29, 2019 | WITHDRAWAL OF ATTORNEY GRANTED |
| Wednesday, May 29, 2019 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
| Monday, January 21, 2019 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, January 21, 2014 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, December 19, 2013 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Wednesday, December 18, 2013 | LAW OFFICE REGISTRATION REVIEW COMPLETED |
| Thursday, December 12, 2013 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Wednesday, November 20, 2013 | STATEMENT OF USE PROCESSING COMPLETE |
| Friday, October 11, 2013 | USE AMENDMENT FILED |
| Tuesday, November 12, 2013 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, October 11, 2013 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, April 30, 2013 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 5, 2013 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 5, 2013 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 13, 2013 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, January 30, 2013 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, January 22, 2013 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, January 17, 2013 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, January 16, 2013 | ASSIGNED TO LIE |
| Wednesday, January 16, 2013 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, January 16, 2013 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, January 16, 2013 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, January 7, 2013 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, January 7, 2013 | NON-FINAL ACTION E-MAILED |
| Monday, January 7, 2013 | NON-FINAL ACTION WRITTEN |
| Monday, December 17, 2012 | ASSIGNED TO EXAMINER |
| Saturday, December 1, 2012 | ASSIGNED TO EXAMINER |
| Tuesday, August 14, 2012 | NOTICE OF PSEUDO MARK MAILED |
| Monday, August 13, 2012 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Tuesday, August 7, 2012 | NEW APPLICATION ENTERED IN TRAM |